If you have browsed Chinese e-commerce lately, you have likely seen them: a band that sits on your head and promises to "boost focus," "train your brain," or make a child "twice as efficient at studying," priced anywhere from a few hundred to a few thousand yuan. Most are consumer-grade brain-computer interface (BCI) gadgets — devices that read electrical activity from the scalp. On September 1, the southern tech hub of Shenzhen moved to regulate exactly this kind of product, publishing the Shenzhen Special Economic Zone Provisions to Promote Innovative Development of the Brain-Computer Interface Industry (Draft for Comment). The document lays down three explicit red lines.
For readers outside China: Shenzhen is the country's densest cluster of both BCI startups and consumer-electronics supply chains — the same city that hosts the world's leading drone and smartphone manufacturers — which makes it the natural place to test how a government can both court a frontier industry and fence off its abuses.
Key takeaways
- The draft bans three things: mind control (意识操控), illegal neural-data collection, and products causing irreversible neural damage or using false advertising.
- Violators face inclusion on a research-integrity blacklist and are barred for five years from municipal science-and-technology funding.
- Shenzhen will also promote the industry: a leader-firm cultivation pool, new BCI job titles, and green channels for approved products in centralized procurement.
- A national standard for BCI multimodal data formats was released alongside, enabling devices from different makers to interoperate.
- Neighboring Zhejiang province will implement its own 18-measure BCI plan on September 10, targeting over 50亿元 (about $694 million / HK$543 million) in industry revenue by 2027.
Why Shenzhen, and why now
Shenzhen is one of China's most concentrated cities for BCI enterprises, and it sits next to the world's most mature consumer-electronics manufacturing base. That combination means it understands the technology and, just as importantly, how easily a "consumer BCI product" can slide into hype and harm. The logic of the provisions is two-handed: one hand promotes the industry, the other draws a floor.
The promotional hand is concrete. The city will build a cultivation pool for leading firms, fold BCI-related new job categories into the national occupational classification, count clinicians' participation in BCI research toward their professional-title evaluation, give research wards separate assessment that does not consume ordinary bed quotas, and open green channels on centralized-procurement platforms for products that have already won registration.
The regulatory hand deserves more attention. Clinical research must pass both academic and ethics review and be filed with the national health authority. That requirement is the substantive content behind the "red lines" headline.
The national floor is arriving too
Running in parallel, China published national standards including Information Technology — Brain-Computer Interface — Multimodal Data Format, which unifies how EEG (electroencephalogram) data is stored and exchanged. This sounds dry but matters enormously: only with a common format can devices from different manufacturers talk to each other and can clinical data be reused across sites. It is the prerequisite for BCI to move from "every lab its own format" to scaled application.
At the provincial level, Zhejiang's Several Measures to Advance BCI Industry-Academia-Research Linkage — eighteen articles in total — takes effect September 10, with a 2027 goal of nurturing more than five deployed products and industry revenue above 50亿元 (about $694 million / HK$543 million).
Three ways for consumers to avoid the traps
Reading the spirit of the new rules, the reporting distills three practical checks for buyers:
- Walk away from anything claiming to "read minds," "control objects," or "raise IQ." The draft explicitly bans mind control and false advertising. Today's non-invasive devices are realistically limited to attention monitoring, relaxation training, and rehabilitation assistance — nowhere near "reading thoughts."
- Look for a medical-device registration number (械字号). Anything meant for clinical diagnosis must hold a medical-device registration certificate. Without it, the product is essentially a consumer gadget; do not treat it as medicine.
- Be cautious about authorizing your neural data. Neural signals are among the most sensitive biometric information there is — more private than a fingerprint or a face. The rules specifically prohibit illegal collection, which is a reminder to check, before using such an app, exactly what it gathers and where it sends the data.
What an ordinary person can do now
The reporting offers grounded advice rather than anxiety. For families with rehabilitation needs, choose products with registration certificates and proper hospital rehabilitation departments, not "home miracles." For parents eyeing focus-training headbands, get a professional assessment at a hospital first — a few-hundred-yuan band will not solve a medical issue. And for the curious, the Beijing Wellness Expo on September 3–5 hosts, for the first time domestically, a dedicated BCI zone where real products can be seen in person, which beats any advertisement.
The line worth keeping is the one the original piece closes on: drawing red lines for a new technology is not pouring cold water on it — it is letting the things that genuinely work survive long enough to be proven.
Honest limitations
This article summarizes a draft-for-comment document, not a finalized law; provisions may change before adoption, and the public-comment window means the three red lines are proposals rather than enacted binding rules at the time of writing. The specific penalty mechanisms (five-year funding bar, research-integrity blacklist) are described in the draft as reported and have not been tested in enforcement. The Zhejiang 50亿元 revenue target is a provincial policy goal, not a forecast with independent backing. Dollar and Hong Kong-dollar conversions use approximate rates (1 USD ≈ 7.2 RMB; 1 HKD ≈ 0.92 RMB) and are indicative only. The consumer-product cautions reflect the outlet's interpretation of the rules, not formal legal guidance; readers should consult the published draft and qualified counsel for compliance questions.
Sources
Based on reporting by the Chinese tech outlet Naojiwang (脑机派对), 2026-09-02, citing the Shenzhen draft provisions, concurrently released national BCI data-format standards, and Zhejiang provincial measures.